FDA Approves Voluven To Treat Serious Blood Volume Loss During And After Surgery
The U.S. Food and Drug Administration today approved Voluven, an intravenous solution that prevents and treats a dangerous loss of blood volume, a condition that sometimes occurs during and after surgery. Significant blood losses can cause a rapid drop in the volume of red blood cells and plasma circulating through the body...[read article]
Plan To Put Europe At Forefront Of Medicines Research Has UK Backing
An initiative designed to place Europe at the forefront of medicines research and development has received strong backing from the Association of the British Pharmaceutical Industry (ABPI) today...[read article]
Confidential Treatment Programs For Physicians With Mental Illness - Statement Of American Medical Student Association
Bladder Substitution By Ileal Neobladder For Women With Interstitial Cystitis
Fujirebio: Researchers Identify Indicator Of Ovarian Cancer
Blue Cross And Blue Shield Of North Carolina Waives Copayments On Drugs For Chronic Conditions
AspenBio Outlines Steps For FDA 510(k) Clearance Of AppyScore(TM), The First Blood-Based Screen/Triage Test For Human Appendicitis
Newly Formed Council Issues Statement On Healthcare Provider Gaps Related To Education And Management Of Fibromyalgia Syndrome
AARP Calls Medicare Bill "Woefully Inadequate"
New Course Provides Refresher And Certification For Surgeons Performing Laparoscopic Surgery
Beyond The Abstract Sympathomimetic Amine Therapy May Improve Refractory Gastroparesis Similar To Its Effect On Chronic Pelvic Pain--Case Report
Yeast Research Improves Understanding Of Chromosome Events Leading To Infertility And Birth Defects
No comments:
Post a Comment